11-30231952-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001382289.1(FSHB):c.50G>A(p.Cys17Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382289.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSHB | NM_001382289.1 | c.50G>A | p.Cys17Tyr | missense_variant | Exon 2 of 3 | ENST00000533718.2 | NP_001369218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSHB | ENST00000533718.2 | c.50G>A | p.Cys17Tyr | missense_variant | Exon 2 of 3 | 1 | NM_001382289.1 | ENSP00000433424.1 | ||
FSHB | ENST00000254122.8 | c.50G>A | p.Cys17Tyr | missense_variant | Exon 2 of 3 | 5 | ENSP00000254122.3 | |||
FSHB | ENST00000417547.1 | c.50G>A | p.Cys17Tyr | missense_variant | Exon 2 of 3 | 5 | ENSP00000416606.1 | |||
ARL14EP-DT | ENST00000662729.1 | n.293-75099C>T | intron_variant | Intron 3 of 4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 251038Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135656
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461618Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727120
GnomAD4 genome AF: 0.000131 AC: 20AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74330
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.50G>A (p.C17Y) alteration is located in exon 2 (coding exon 1) of the FSHB gene. This alteration results from a G to A substitution at nucleotide position 50, causing the cysteine (C) at amino acid position 17 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at